Video Experimental Relacionado
Updated: Aug 10, 2026
07:13
Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
El receptor de AMP cíclico desencadena la fosforilación de proteínas nucleares en un sistema libre de células
Science (New York, N.Y.)
|September 28, 1979
Resumen
Una proteína específica del receptor de AMP cíclico aumenta en los tumores mamarios. Esta proteína se mueve hacia el núcleo y ayuda en la fosforilación de proteínas nucleares, lo que sugiere su papel en los tumores mamarios dependientes de hormonas.
Área de la Ciencia:
- Biología molecular La biología molecular.
- Investigación de la investigación del cáncer.
- La bioquímica es la bioquímica.
Sus antecedentes:
- Los tumores mamarios dependientes de las hormonas exhiben cambios moleculares complejos.
- Las vías de señalización de adenosina 3',5'-monofosfato (AMP cíclico) son cruciales en la regulación celular.
Objetivo del estudio:
- Para investigar el papel de la proteína del receptor AMP cíclico en los tumores mamarios inducidos por el 7,12-dimetilbenzo[a]antraceno (DMBA).
- Para dilucidar los eventos nucleares que involucran al receptor de AMP cíclico en estos tumores.
Principales métodos:
- Incubación de las rebanadas de tumores mamarios inducidas por DMBA con AMP cíclico, benzamida y arginina.
- Incubación del citosol tumoral con núcleos tumorales para evaluar la captación nuclear y la fosforilación de proteínas.
- Utilizando la proteína quinasa del corazón bovino tipo II para estudiar la unión nuclear y la fosforilación.
Principales resultados:
- Una proteína del receptor AMP cíclico de 56.000 daltones aumentó significativamente en los tumores mamarios inducidos por DMBA después de la incubación.
- El receptor de 56.000 daltones fue sometido a captación nuclear y facilitó la fosforilación de una proteína nuclear de 76.000 daltones.
- La unión al receptor y la fosforilación de proteínas también se observaron en núcleos tumorales de DMBA utilizando proteína quinasa exógena tipo II.
Conclusiones:
- La proteína del receptor AMP cíclico de 56.000 daltones juega un papel en los eventos nucleares de los tumores mamarios dependientes de las hormonas.
- La participación del receptor de AMP cíclico en los procesos nucleares sugiere un mecanismo potencial en el desarrollo de tumores mamarios.
Videos de Conceptos Relacionados
01:12What are Second Messengers?
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
01:24Intracellular Signaling Cascades
Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...